Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Figure 1 | BMC Cancer

Figure 1

From: Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy

Figure 1

Classification of melanoma cell lines according to alterations in NRAS / BRAF genes and p16 CDKN2A /pERK 1-2 protein expression. Data regarding occurrence of mutations in BRAF/NRAS genes (mut), down-regulation of p16CDKN2A protein (p16-), and over-expression of phosphorilated ERK1-2 protein (pERK1-2+) are indicated. Exemplificative immunochemical results are shown.

Back to article page